AADI Stock: Aadi Bioscience, Inc. Stock Price, Analysis & Insights
Get live aadi stock price $2.05, comprehensive Aadi Bioscience, Inc. stock analysis, charts, news, and expert forecast. Real-time aadi stock data and investment insights.
Loading chart...
Company Overview
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Company Information
- CEO
- David J. Lennon
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 53
Contact Information
- Website
- https://aadibio.com
- Address
- 17383 Sunset Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.34) may provide portfolio stability
Business Model & Strategy
Aadi Bioscience, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO David J. Lennon, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Aadi Bioscience, Inc. competes in the Biotechnology within the broader Healthcare. With 94.9 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Aadi Bioscience, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Aadi Bioscience, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Aadi Bioscience, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Aadi Bioscience, Inc.
- ⚠Investors should consider how Aadi Bioscience, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
94.89M
P/E Ratio
-0.87
Beta
0.34
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 94.89M market capitalization
- Trading Volume: 62.61K shares traded today
- Price Range: 52-week range of $1.21 - $3.81
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Aadi Bioscience, Inc.
Aadi Bioscience, Inc. (AADI) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 94.89M, the company represents a significant player in its market. The stock is currently trading at $2.05 with a negativedaily change of 2.38%.
The company's 53 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.87, beta of 0.34, and 52-week price range from $1.21 to $3.81when evaluating investment opportunities.
Why Invest in Aadi Bioscience, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under David J. Lennon
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.